Houdini Bio is a deep tech biotechnology company providing the critical enabling infrastructure for next-generation genetic medicines. By combining machine learning with a mechanistic understanding of cellular silencing pathways, Houdini Bio's DNA rewiring toolkit allows therapy developers to maximise transgene expression, durability and scalably. Headquartered in London, Houdini Bio is unchaining the full potential of genetic medicine to make tomorrow's curative therapies more commercially viable, effective and clinically safe.